chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Red circle, 3 inches in diameter, warm to touch, a bit swollen, itches occasionally.
Patient was administered Moderna booster 0.25 mL at age 17. Patient was 2 months before 18th birthday. Reviewed error with patient's mom. She stated he had no atypical reaction and even no typical reactions at all.
Pt. developed shingles infection on forehead and (R) upper eyelid 2 days after SHINGRIX vaccine given.
PATIENT ADMINISTERED THE HIGH DOSE FLU SHOT WHEN INELIGIBLE DUE TO AGE. PATIENT IS 64 YEARS OLD.
Case number PHEH2012US006923 is an initial spontaneous report received from a medical assistant on 22 Mar 2012. This case refers to a 17-year-old male patient. He was vaccinated with MENVEO (batch number: X10054) intramuscularly on 28 Feb 2012. The reporter stated that this patient was administered MenCYW -135 liquid conjugate component of MENVEO only, instead of reconstituting with MenA lyophilized conjugate component of MENVEO. No adverse event have occurred since administration.
arm pain; muscle pain; This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 62-year-old female patient who received Herpes zoster (Shingrix) (batch number G72ZD, expiry date 24th November 2020) for prophylaxis.   On 10th April 2019, the patient received the 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced pain in arm and muscle pain. On an unknown date, the outcome of the pain in arm and muscle pain were recovered/resolved.   It was unknown if the reporter considered the pain in arm and muscle pain to be related to Shingrix.  Additional details were provided as follows: The pharmacist reported that a patient had the 2nd injection of Shingrix after they complained of arm pain, muscle pain, long term reaction for 6 weeks or more.  The case has been linked with the case US2019AMR099873 (husband's case), reported by same reporter.
2mins post vaccination pt had a syncopal episode and associated dizziness @15:08 from a standing position.  Pt hit posterior lower skull on floor after entry into obs area. No LOC no change in vision or hearing.  States did not eat or drink much today. Vitals: 15:10 sitting 92/47, 114, 12, 100% O2 Sat -- > 15:22 lying 86/47, 88, 12, 100% -- > 15:42 lying 101/60, 93, 12, 100% 15:45 sitting 93/53, 85, 12, 100%.   Mother consulted pediatrician who advised the pt to wait for 30mins then ok to leave if pt feels well.  MD to call back in 1hr.  Pt stable and released from the vaccination site.  Pt to car via w/c w/ RN and mother. Less dizziness, AxO x 4.  Advised to drink water and supplement w/ pedialyte.  F/u w/ PCP as directed or if s/s worsen.  Future vaccinations supine
pt recvd vax;red,swollen area;"soft ball" size, itching per mom;occured w/in 24 hrs of vax in rt muscle; area felt warm;afebrile;has had d since eve of vax;
Patient was given an extra dose of IPOL. CMA giving vaccine was busy at time before getting vaccines ready and forgot that there is Polio in the Pediarix vaccine already. She did not realize it until after vaccines were given. Patient's mother was contacted regarding the mishap and stated patient was doing fine. He only had a small localized reaction at injection site of redness.
Pain at anterior neck and lower jaw, thyroid swelling, pain swallowing for two months after vaccination. This was 4th dose of Covid -19 vaccine
fever of 100.6 degrees farenheit that was noticed upon waking at 10am.
Pt exp inc tactile temp; was sponged; Lips turned blue, went limp, high pitched cry; Taken to ER dx w/vax rxn;
On day 2 after receipt of MMR 7/6/10, developed 104 degrees F. fever, muscle aches and headache not relieved w/ TYLENOL. Also (R) ankle pain at site of old injury. On 7/12/10, temp. is normal and has only residual.
flu for two days; Lump in clavicle; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 26Mar2021 at 16:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol. The patient did not have any allergies to food, medications, or other products. Concomitant medications included ubidecarenone (COQ10) and unspecified statin for unknown indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the right arm on 05Mar2021 at 15:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021, the patient had flu for two days and lump in clavicle. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events flu for two days and lump in clavicle. The clinical outcomes of the events flu for two days and lump in clavicle were not resolved at the time of the report.   No follow-up attempts are needed. No further information is expected.
A report has been received from a Health Professional concerning a patient born on 30-Dec-2009, male subject, who had been receiving nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on an unknown date. It was reported, they gave expired FLUMIST QUADRIVALENT to the patient (Preferred Term: Expired drug administered).The outcome of the event of gave expired FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious by the reporter.
Narrative: 73 yo male received both COVID-19 bivalent booster and influenza vaccine on same day/time. Shortly after began to have fevers and SOB. After 4 days  of these sxs, reported to ED. Had been taking APA, which provided relief for 4-5 hours at a time. Denied chest pain. Patient with history of asthma/COPD. Treated for COPD exacerbation with methylpred.
Report 2001011457-1 describes a bump at the injection site of an unspecified number of children of unspecified age and gender who received injections of Infanrix at unspecified dates, the children received their fouth dose of Infanrix. Some of the children received vaccine from lot DTPA986A2, and some received vaccine from lot DTPA992A2. No other vaccines were injected into the same leg as Infanrix. At some later time, the parents of the children reported that the children had developed a bump at the injection site. All the children recovered. The reporter was unable to specify the number of children who experienced this event and was unable to provide identifiers for any of the children, because no records of these events were maintained in the office. Since there are no identifiable patients, this report is considered not reportable.
pt recv vax 15FEB96 & was found to be pregnant (LMP 11JAN96 estimated date of delivery 19OCT96); pt devel a rash @ the inj site; during preg exp nausea, constip, abd cramps, tightness beneath breast, indigestion, back discomfort; nl delivry
Both injections caused nausea, vomiting, diarrhea, fever, fatigue, body aches, and low appetite. The second dose was administered 10/20/21. Symptoms last for 3 days.
Patient came to the pharmacy to inform us that she had side effects following the administration of her COVID vaccine. She stated she was clammy, her body was hot and cold. She experienced nausea and vomiting. She took a a shower to cool off. She was dizzy and had the sore arm.
This spontaneous report was received from a physician via company representative refers to a 13 year old female patient. On an unknown date, the patient was vaccinated with a second dose of GARDASIL, (lot number, expiry date and route was not reported). On an unknown date, the patient developed pseudo-seizures (disability), other central nervous system issues (disability) and headache (disability) 2 weeks after receiving the second dose of GARDASIL. Due to these adverse events the patient had to use a wheel chair. The outcome of the reported events were not recovered. The patient sought medical attention (patient saw the physician). Additional information has been requested.
Redness above the bandaid; This is a spontaneous report for a non-contactable consumer (patient mother). A unspecified age male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: unknown), via intramuscular route of administration, on an unknown date, as a 2nd dose, single for COVID-19 Immunisation. The patient's medical history and concomitant medications were not reported. Historical vaccination included first dose of BNT162B2 for COVID-19 immunisation. On an unknown date, within minutes of vaccination, the patient experienced redness above the band aid and then it went away after 5 minutes. The consumer stated she read about on proper preparation/dilution instructions such as she knows it was good for 6 hours in the vial after dilution and to keep it away from light. The consumer just wanted to ensure it was done right and she was not sure if nurse inverted it. She will follow up with the nurse who administered vaccine but wanted to ask manufacturer. Asked if the vial needs to be inverted 10 times gently prior to each dose being drawn up in syringe and whether pfizer gives the instructions to facilities and also in the case of if someone inverted it prior to drawing up dose in syringe (after already been inverted) would Pfizer want to know that. Consumer added that she knows for some facilities they leave the diluted vial exposed to light, she was unclear which facility. Consumer also stated that they did not inserted the entire needle for his son, they inserted it almost all the way because of concern hitting bone with his small arm. She was told by nurse that they usually do that with kids. The outcome of the event erythema was recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
had 5 weeks of peripheral neuropathy - pain and sensitivity to left triceps and left pectoralis area/chest wall. no weakness. saw a neurologist.
Pruritis, swelling of upper arm, pain, redness, soreness all on right arm (PNEUMOVAX).  Pt is taking BENADRYL for current treatment.
Aseptic Meningitis - Bacterial and Viral Cultures negative.  Hospitalized for 5 days, received antibiotics for 48 hrs. until cultures confirmed negative.  3/19/08 Reviewed hospital medical records of 1/28-2/1/2008 admission. FINAL DX: Aseptic meningitis & SIADH. Records reveal patient experienced HA x 5 days, fever & nausea/vomiting x 2 days.  Seen by pcp & also noted to have photophobia, meningismus, dehydration & gen myalgias.  LP done.  Tx w/IVF, IV antibiotics.  Discussed w/ID.  Continued to be febrile through d/c but clinically improved. D/C to home w/pcp f/u.
Arm sore; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain in arm (Verbatim: Arm sore). The outcome of the pain in arm was not reported.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     It was unknown if the company considered the pain in arm to be related to Shingles vaccine.   Additional Information: GSK receipt date: 19-MAR-2023 This case was reported by a patient via interactive digital media. The patient stated that nothing more than her/his arm being a little sore. so, no real side side effects. The follow-up could not be possible as no contact details were available.
Body Rash; This is a spontaneous report from a contactable consumer (patient). A 79-year-old male patient received bnt162b2 (BNT162B2, Lot Number: EL9261), dose 1 via an unspecified route of administration, administered in Left arm on 27Jan2021 16:15 (at the age of 79-year-old) as dose 1, single for Covid-19 immunization. The patient medical history was not reported. Concomitant therapy included unspecified vaccine administered in Left arm on 21Feb2021(Lot Number: EN6201). The patient experienced body rash on 30Jan2021 17:30. The patient received no treatment for the event. The outcome of the event was not recovered.    No follow-up attempts are possible. No further information is expected.
Narrative: Admission Date: AUG 29,2021 Discharge Date: AUG 30,2021 Admit Diagnosis: Covid + 72 yo M w a PMH T2DM, HTN, COPD (not on home O2), CKD on hemodialysis (MWF), CAD, hx substance abuse, prostate cancer (Dx 2017), hep C (treated), who presented with worsening cold-like symptoms of 1 week duration. Patient says that for the past 7 days he has been having worsening fatigue, congestion, mild SOB, and productive cough. He also says that he has been feeling like he's choking . During this time he did not have any subjective fevers, night sweats or chills. Patient also denied any headaches, dizziness, chest pain, nausea, vomiting, bloody bowel movements, hemoptysis, or hematemesis for the past 7 days. When presented to the emergency department, patient was hemodynamically stable, T 98.6, P 75, RR 20, BP 107/66. Covid test was performed which came back positive. Patient previously received two doses of the Pfizer Covid vaccine (2/5/2021 and 2/26/2021). CXR with minimally changed radiographic findings, apart from the new right sided tunneled catheter. Patient was admitted to the Medicine Service for further management. #COVID+ pneumonia/pneumonitis: Patient with covid-like symptoms of 1-week duration. Fatigue, cough, congestion, mild SOB. Has not required supplemental O2 - therefore, dexamaethasone and remdisivir held. Gave Regeneron (8/30) given high risk PMH (COPD, ESRD) and positive test <10 days ago. Discharged on 8/30 in stable condition.
On August 29th, 2021, I started to have symptoms of a sore throat for about two and a half days.  On August 31st, 2021 I tested positive for COVID-19, I started to feel really fatigued. I did not think I had COVID-19 but I did.  I was called on Wednesday September 1, 2021, Hospitals and Clinics  Specialty Clinics Pharmacy. Pharmacist told me that I was eligible for the antibody infusion. I went the same day to get the antibody infusion.  September 2-3, 2021, I was feeling really fatigued and I laid down all day, and the following few days I started to feel a little better.
Dizziness when standing up, lasted about 1 hour. Hydration helped greatly after symptom occurred
Information has been received from a physician via a company representative referring to a 14 year old male patient. On an unknown date the patient was vaccinated with GARDASIL 9 (dose, lot# and route were unknown). Concomitant therapy included hepatitis a vaccine, inactivated (manufacturer unknown). On 02-MAR-2016 the patient passed out and hit his head on the door. The patient visited the doctor for the events on an unknown date. The patient recovered from the events in March 2016. Causality was not provided. Additional information has been requested.
My symptoms progressed 3-4 days after getting the vaccine. By Feb 8th I started having visible swelling of my ankles and feet, along with mental fogginess. I started developing petechiae on my feet. By Feb 12th the petechiae were all over my body and I had increased swelling. I went to urgent care attached to the hospital on Feb 12th, the lab work showed a platelet count of 3,000.  They diagnosed me with immune thrombocytopenia and I was admitted to the hospital. After the vaccine, my immune system attacked my platelets so I couldn't clot. I was given a platelet transfusion, IV-Ig and steroids on Feb 13th. I was inpatient for about 4 days. Once my platelets were back up, I have been experiencing shortness of breath. I still experience brain fog and memory problems. I still receive follow up medical treatment. I have seen a neurologist, to order a cognitive testing. I have seen cardiology and pulmonology because I am barely able to walk 100 yards without losing my breath now. The exercise intolerance is ongoing.
Patient received her 2nd dose of COVID (Pfizer).  She walked out of the immunization room to wait in the store, made it about 2 aisles over, and fainted.  Patient's father and the Pharmacist immediately got to her side.  She came to within less than 1 minute.  In the meantime EMS was called and the Pharmacist waited with the patient until they arrived.  EMS looked over the patient and patient was able to leave on her own after waiting out the nausea and dizziness that had occurred.  Patient also reported a headache which was most likely from hitting her head on the way down.
Patient administered Varicella Vaccine on 1/21/03.  Developed Fever 102, and small papules, some of which have mild vesicular component centrally, consistent with Varicella.
Patient had allergic reaction to Moderna vaccine dose #1 - Within 15 minutes of receiving vaccine - patient began to experience tingling of the tongue that spread across the tongue - she was administered an Epi-pen and then was given Benadryl and Prednisone.  Patient's symptoms did improve after administration of Epi-pen and other medications above.  I followed up with the patient
Immediately after the dose has been administered: Extreme dizziness, blurred vision, throat constriction, aches, muscle cramps, lightheaded, extreme chills, feeling hot and cold
This spontaneous report as received from a pharmacist refers to a patient of unknown age. On an unknown date, the patient was vaccinated with an expired vial PNEUMOVAX 23, route and lot number not provided. No adverse reactions were reported. There was a product quality issue involved. Additional information has been requested.
None.Dose of pfizer monovalent administered on 04/20/2023 after authorization was cancelled on 04/18/2023.Patient contacted,Denies any adverse event.Revaccination reccomended.
This spontaneous report as received from a physician via company representative regarding a 15 or a 16 year old male patient with concurrent condition of epilepsy. Information regarding patient's medical history, drug reactions and allergies were reported as unknown. Information regarding patient's past therapies was not reported. On an unspecified date in January 2017, the patient was vaccinated with second dose of either GARDASIL (unidentified Merck hpv vaccine administered (name and lot number not provided)) or GARDASIL 9 (unidentified Merck hpv vaccine administered (name and lot number not provided)), via intramuscular route for prevention of human papilloma virus (HPV) (dose and expiry date were reported as unknown). On the same day, the patient was also vaccinated with TRUMENBA and possibly but not completely certain MENACTRA for prophylaxis (dose, route, lot number and expiry date were not reported). On an unspecified date in February 2017 (reported as about a year ago and about a month after receiving these vaccines), the patient experienced seizure. It was reported that patient went to an unspecified hospital but it was unknown if patient had visited emergency room or admitted to the hospital. It was unknown if patient had received any treatment for the adverse event. It was unknown if any lab diagnostics or any studies performed. The outcome of the event was reported as recovered on an unknown date. The reporter assessed the causal relationship of event to patient's pre-existing epilepsy. The causality with suspect therapies was unknown. It was reported that there was no product quality complaint (PQC) involved in the report. Upon internal review, the event seizure was determined to be medically significant.
Pt received second Moderna vaccine today. During the 15 minute waiting period after the vaccine; he reported that his chest, back and torso felt tight and almost felt if he were having muscle spasms. We called the squad and had him sit down to rest. He said it felt better to stand and he tried relieving the discomfort by stretching his lower back.  We checked his blood pressure (131/90) and asked if he wanted a bottle of water.  He said that the feeling was beginning to fade and by the time the squad arrived; he said the felling had passed and he felt fine.
Bilateral eye swelling with erythema and itching. Patient also complained of foot itching. Patient given BENADRYL in office and referred to ER.
During call to schedule second dose of SHINGRIX vaccine, patient states she experienced some side effects following the first injection that made her question whether she wanted to get the second dose.  Patient reported some pain starting at the injection site in her arm that radiated down to her hip on the same side and then lead to a "strip of numbness" along that one side of her body where the pain had radiated from initially. She also reported some swelling in her left foot that developed a few days following the injection that resolved with the rest of her symptoms within about a week--- she had contacted her doctor's office via phone to inquire about her symptoms when they first started so that they were aware as she continued to monitor them at home. She has no residual symptoms or issues at this time, but is hesitant to receive the second dose.
Patient recieved varicella vaccine on 11/14/2002.  Recieved call from mother of patient stating that beginning on 01/15/2003, patient began to break out with chicken pox.  At 10:30 am, 1/16/2003, patient had over 100 varicella lesions over trunk and legs
Passing out, extreme weakness, vomiting, fever, cool sweat, extreme fatigue, diarreah, skin rash, 4 day headache.  Considered calling 911 but I was on the floor too weak to get to the phone.
Tdap, MCV4, and VZ were adminstered without problems. Patient up in clinic chose treat and left clinic. Patient had a syncopal episode in the parking lot and suffered abrasions to face. Patient treated in clinic and recovered BP and HR in less than 20 minutes. Minor abrasions cleansed and treated. Patient left clinic ambulatroy.
Left arm injection site swollen and hard knot. Hot to the touch. Left neck lymph node swollen. Both areas sore and tender.
Baby was DOA at hospital. Death certificate listed bruises found on head and cause of death as traumatic injuries of head and abdomen.  4/29 Autopsy states COD as traumatic injuries of head & abdomen.  Manner of death: homicide.  4/29/08 Autopsy report states patient experienced irritability, fever, vomiting & diarrhea since vaccination w/o medical attention.  Patient had been to ER x 3 for vomiting 3 times since birth, last on 12/7/2006.  Contusion in center of forehead noted in ER w/o explanation by parents.  Findings at autopsy included: extensive nearly transmural lacerations of the liver w/hemoperitoneum; mod soft tissue bleeding in abdomen, pelvis & lower chest including involvement of left lung; mid-mod SAH; healing posterior paravertebral fractures of right ribs 7 & 11 and left ribs 3-8; mild-mod contusions & abrasions of skin & sq tissue of head, torso & right leg; mild bronchitis & mild trachitis.  Metabolic, chemical & tox tests neg.  These injuries resulted in a significant amount of bleeding on the surface of the brain & into the abdominal cavity.
pt recvd vax 15JUN94 & w/in 7 hrs exp urticaria from head to toe; No other sx; rx'd w/DPH; 16JUn sx improving; pt recovered w/in 12 hrs;